
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5582297
[patent_doc_number] => 20090101499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Protein-Immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor'
[patent_app_type] => utility
[patent_app_number] => 11/920782
[patent_app_country] => US
[patent_app_date] => 2006-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5700
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20090101499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920782 | Protein-Immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor | May 17, 2006 | Abandoned |
Array
(
[id] => 303299
[patent_doc_number] => 07534435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Glycosylated specificity exchangers'
[patent_app_type] => utility
[patent_app_number] => 11/411294
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20304
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534435.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411294
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411294 | Glycosylated specificity exchangers | Apr 25, 2006 | Issued |
Array
(
[id] => 5205020
[patent_doc_number] => 20070026502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Specificity exchangers that redirect antibodies to a pathogen'
[patent_app_type] => utility
[patent_app_number] => 11/412181
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21686
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11412181
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/412181 | Specificity exchangers that redirect antibodies to a pathogen | Apr 25, 2006 | Abandoned |
Array
(
[id] => 5890407
[patent_doc_number] => 20060276621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Glycosylated specificity exchangers'
[patent_app_type] => utility
[patent_app_number] => 11/411454
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18466
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276621.pdf
[firstpage_image] =>[orig_patent_app_number] => 11411454
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/411454 | Glycosylated specificity exchangers | Apr 25, 2006 | Issued |
Array
(
[id] => 8549047
[patent_doc_number] => 08323928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease'
[patent_app_type] => utility
[patent_app_number] => 11/277456
[patent_app_country] => US
[patent_app_date] => 2006-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 7585
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11277456
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/277456 | Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease | Mar 23, 2006 | Issued |
Array
(
[id] => 8257271
[patent_doc_number] => 08206750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Charged lipoprotein complexes and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/388135
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18874
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11388135
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388135 | Charged lipoprotein complexes and their uses | Mar 21, 2006 | Issued |
Array
(
[id] => 5310166
[patent_doc_number] => 20090017447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/909001
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23420
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20090017447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909001 | Human endogenous retrovirus K102 with foamy-virus-like properties and uses thereof | Mar 19, 2006 | Issued |
Array
(
[id] => 5397355
[patent_doc_number] => 20090317418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'VACCINES AND METHODS FOR PREVENTION AND TREATMENT OF DRUG-RESISTANT HIV-1 AND HEPATITIS B VIRUS'
[patent_app_type] => utility
[patent_app_number] => 11/816704
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33109
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317418.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816704
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816704 | Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus | Feb 21, 2006 | Issued |
Array
(
[id] => 5391612
[patent_doc_number] => 20090208925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Methods and Compositions for Determining Hypersusceptibility of HIV-1 to Non-Nucleoside Reverse Transcriptase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/884667
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18962
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208925.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884667
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884667 | Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors | Feb 15, 2006 | Issued |
Array
(
[id] => 602167
[patent_doc_number] => 07431928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-07
[patent_title] => 'Identification of new CD8 epitopes from HIV-1 proteins'
[patent_app_type] => utility
[patent_app_number] => 11/339605
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8254
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/431/07431928.pdf
[firstpage_image] =>[orig_patent_app_number] => 11339605
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/339605 | Identification of new CD8 epitopes from HIV-1 proteins | Jan 25, 2006 | Issued |
Array
(
[id] => 5873008
[patent_doc_number] => 20060165717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'DCchol in newborns'
[patent_app_type] => utility
[patent_app_number] => 11/338908
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2567
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11338908
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/338908 | DCchol in newborns | Jan 23, 2006 | Abandoned |
Array
(
[id] => 5699622
[patent_doc_number] => 20060216306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Epitopes of human immunodeficiency virus-1'
[patent_app_type] => utility
[patent_app_number] => 11/302312
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9345
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302312 | Epitopes of human immunodeficiency virus-1 | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5404480
[patent_doc_number] => 20090239794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'HCV F PROTEIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/719635
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26450
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239794.pdf
[firstpage_image] =>[orig_patent_app_number] => 11719635
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719635 | HCV F PROTEIN AND USES THEREOF | Nov 17, 2005 | Abandoned |
Array
(
[id] => 5148760
[patent_doc_number] => 20070048820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion'
[patent_app_type] => utility
[patent_app_number] => 11/258963
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15601
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11258963
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/258963 | Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion | Oct 24, 2005 | Issued |
Array
(
[id] => 9238219
[patent_doc_number] => 08603006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Method and apparatus for detecting ineffective inspiratory efforts and improving patient-ventilator interaction'
[patent_app_type] => utility
[patent_app_number] => 11/664730
[patent_app_country] => US
[patent_app_date] => 2005-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 5989
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11664730
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664730 | Method and apparatus for detecting ineffective inspiratory efforts and improving patient-ventilator interaction | Oct 19, 2005 | Issued |
Array
(
[id] => 5799367
[patent_doc_number] => 20060034868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Methods and vaccines for providing in ovo protection against turkey rhinotracheitis'
[patent_app_type] => utility
[patent_app_number] => 11/251692
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15741
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251692
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251692 | Methods and vaccines for providing in ovo protection against turkey rhinotracheitis | Oct 16, 2005 | Issued |
Array
(
[id] => 5748619
[patent_doc_number] => 20060111551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Peptide having HTLV-1-specific CTL-inducing activity'
[patent_app_type] => utility
[patent_app_number] => 11/251195
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13190
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111551.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251195
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251195 | Peptide having HTLV-1-specific CTL-inducing activity | Oct 13, 2005 | Abandoned |
Array
(
[id] => 5807269
[patent_doc_number] => 20060093623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection'
[patent_app_type] => utility
[patent_app_number] => 11/243094
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5128
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093623.pdf
[firstpage_image] =>[orig_patent_app_number] => 11243094
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/243094 | Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection | Oct 3, 2005 | Abandoned |
Array
(
[id] => 5648401
[patent_doc_number] => 20060134133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'MVA expressing modified HIV envelope, Gag, and Pol genes'
[patent_app_type] => utility
[patent_app_number] => 11/238155
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 24717
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134133.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238155 | MVA expressing modified HIV envelope, gag, and pol genes | Sep 27, 2005 | Issued |
Array
(
[id] => 7776397
[patent_doc_number] => 20120039923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'Modified HIV-1 Envelope Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/662422
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11979
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20120039923.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662422
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662422 | Modified HIV-1 Envelope Proteins | Sep 8, 2005 | Abandoned |